|
|
Video: Risk Management of Adventitious Agent Contamination in Biopharmaceutical Products
During this podcast, we will discuss the causes and implications of Adventitious Agent Contamination for pharmaceutical and biopharmaceutical manufacturers. We will discuss ways in which Lancaster Laboratories is helping manufacturers minimize the risk for this contamination to avoid production delays. Presenter: Katherine Bergmann, Ph.D.
Online Resources:
|
|
|||||||||||||||||||||||||||||||